Journal rankings · indicator year 2018
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2018
Immunology and Microbiology journal rankings 2018
135 ranked journals · Field in Life Sciences
Immunology and Microbiology has 135 ranked journals in 2018. The median journal has an OJR of 0.95, below the world average of 1.00, down 0.04 on 2017; Q1 starts at OJR 1.34. The top three are Immunity, Nature Immunology, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2018. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2015–2017, the window the 2018 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Immunology and Microbiology (5)
Up to Life Sciences135 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2017. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2015–2017, the window the 2018 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2015–2017 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2009 to 2018. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 5.57Q1 | 16.75 0.23 up from 2017 | 769 | 100% | $10,400 | ||
2Nature ImmunologyNature Portfolio · United States | 4.50Q1 | 12.50 0.98 down from 2017 | 753 | 43% | $12,690 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 3.56Q1 | 10.82 1.22 up from 2017 | 739 | 100% | — | ||
4Journal of Basic and Clinical PharmacyMedknow · India | 3.54Q1 | 11.50 6.85 up from 2017 | 48 | 0% | — | ||
5Science ImmunologyAmerican Association for the Advancement of Science · United States | 3.42Q1 | 9.45 1.05 up from 2017 | 138 | 50% | — | ||
6Nature reviews. ImmunologyNature Portfolio · United Kingdom | 3.36Q1 | 18.56 1.28 down from 2017 | 448 | 26% | — | ||
7Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 3.02Q1 | 8.36 0.10 up from 2017 | 1,742 | 62% | $4,900 | ||
8Seminars in ImmunologyElsevier BV · United States | 2.92Q1 | 8.08 0.54 down from 2017 | 171 | 37% | $4,370 | ||
9Journal of AutoimmunityElsevier BV · United Kingdom | 2.80Q1 | 7.40 0.86 down from 2017 | 362 | 50% | $5,420 | ||
10Mucosal ImmunologyOAElsevier BV · United States | 2.71Q1 | 7.20 0.17 up from 2017 | 388 | 100% | $4,370 | ||
11Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 2.60Q1 | 6.18 0.93 down from 2017 | 189 | 27% | $5,490 | ||
12Clinical & Translational ImmunologyOAWiley · Australia | 2.59Q1 | 8.11 1.53 up from 2017 | 133 | 100% | $3,070 | ||
13Seminars in ImmunopathologySpringer Science+Business Media · Germany | 2.53Q1 | 6.93 0.50 up from 2017 | 182 | 49% | $3,790 | ||
14Current Protocols in ImmunologyWiley · United States | 2.41Q1 | 2.72 5.31 down from 2017 | 55 | 47% | $5,050 | ||
15Annual Review of ImmunologyAnnual Reviews · United States | 2.19Q1 | 22.60 2.03 down from 2017 | 69 | 74% | — | ||
16Journal of Innate ImmunityOAKarger Publishers · Switzerland | 2.15Q1 | 7.71 0.69 up from 2017 | 175 | 100% | $3,590 | ||
17Frontiers in ImmunologyOAFrontiers Media · Switzerland | 2.00Q1 | 5.74 0.67 down from 2017 | 3,122 | 100% | $3,801 | ||
18International Journal for ParasitologyElsevier BV · Australia | 1.93Q1 | 3.72 0.18 up from 2017 | 302 | 47% | $2,880 | ||
19BioDrugsAdis, Springer Healthcare · Switzerland | 1.76Q1 | 5.84 0.85 up from 2017 | 127 | 51% | $5,190 | ||
20Parasites & VectorsOABioMed Central · United Kingdom | 1.70Q1 | 3.68 0.27 down from 2017 | 1,915 | 100% | $3,090 | ||
21Cellular and Molecular ImmunologySpringer Nature · China | 1.67Q1 | 4.77 1.08 down from 2017 | 331 | 100% | $5,190 | ||
22The Journal of ImmunologyAmerican Association of Immunologists · United States | 1.66Q1 | 4.82 0.11 up from 2017 | 3,082 | 20% | $3,500 | ||
23Immunity & AgeingOABioMed Central · United Kingdom | 1.63Q1 | 4.65 0.72 down from 2017 | 76 | 100% | $3,190 | ||
24The AAPS JournalSpringer Science+Business Media · United States | 1.59Q1 | 3.88 0.36 up from 2017 | 446 | 52% | $5,090 | ||
25ImmunologyWiley · United Kingdom | 1.52Q1 | 4.03 0.19 up from 2017 | 455 | 92% | $5,330 | ||
26Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.51Q1 | 3.70 0.20 down from 2017 | 500 | 92% | $3,816 | ||
27Infection and ImmunityOAAmerican Society for Microbiology · United States | 1.50Q1 | 3.34 0.07 down from 2017 | 1,085 | 97% | — | ||
28Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.50Q1 | 3.94 0.22 down from 2017 | 326 | 43% | $4,990 | ||
29Journal of Leukocyte BiologyOxford University Press · United States | 1.47Q1 | 4.13 0.13 down from 2017 | 691 | 57% | $3,800 | ||
30ParasiteOAEDP Sciences · France | 1.47Q1 | 2.72 0.11 up from 2017 | 157 | 100% | $1,695 | ||
31RetrovirologyOABioMed Central · United Kingdom | 1.45Q1 | 4.11 0.29 up from 2017 | 244 | 100% | $2,890 | ||
32Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.43Q1 | 3.76 0.24 down from 2017 | 445 | 37% | — | ||
33Ticks and Tick-borne DiseasesOAElsevier BV · Germany | 1.35Q1 | 3.30 0.42 up from 2017 | 501 | 35% | $3,010 | ||
34Parasite ImmunologyWiley · United Kingdom | 1.34Q1 | 2.75 0.34 down from 2017 | 228 | 39% | $4,220 | ||
35Immune NetworkOASouth Korea | 1.31Q2 | 3.64 0.51 up from 2017 | 131 | 96% | — | ||
36Trends in ImmunologyElsevier BV · United Kingdom | 1.29Q2 | 11.10 0.89 down from 2017 | 297 | 46% | $7,030 | ||
37International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 1.29Q2 | 3.06 0.50 down from 2017 | 45 | 100% | $1,000 | ||
38Cellular ImmunologyElsevier BV · Netherlands | 1.29Q2 | 3.32 0.10 up from 2017 | 346 | 31% | $3,550 | ||
39Zoonoses and Public HealthWiley · Germany | 1.27Q2 | 2.49 0.12 up from 2017 | 257 | 36% | $4,880 | ||
40European Journal of ImmunologyWiley · Germany | 1.27Q2 | 3.29 0.26 down from 2017 | 909 | 83% | $4,550 | ||
41Vector-Borne and Zoonotic DiseasesMary Ann Liebert, Inc. · United States | 1.27Q2 | 2.44 0.09 down from 2017 | 380 | 21% | — | ||
42International Reviews of ImmunologyTaylor & Francis · United States | 1.25Q2 | 4.27 1.55 up from 2017 | 85 | 27% | — | ||
43CytokineElsevier BV · United Kingdom | 1.25Q2 | 2.85 0.58 down from 2017 | 891 | 25% | $3,220 | ||
44Clinical ImmunologyElsevier BV · Netherlands | 1.24Q2 | 3.38 0.06 up from 2017 | 593 | 33% | $4,400 | ||
45Molecular ImmunologyElsevier BV · Netherlands | 1.23Q2 | 3.27 0.03 down from 2017 | 793 | 15% | $3,340 | ||
46Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 1.21Q2 | 2.59 0.46 down from 2017 | 139 | 100% | $3,490 | ||
47Immunology and Cell BiologyWiley · Australia | 1.15Q2 | 3.55 0.39 up from 2017 | 360 | 54% | $3,750 | ||
48BMC ImmunologyOABioMed Central · United Kingdom | 1.14Q2 | 2.71 0.62 down from 2017 | 170 | 100% | $3,090 | ||
49Immunological ReviewsWiley · United States | 1.11Q2 | 12.57 1.82 up from 2017 | 327 | 60% | $5,000 | ||
50Drug Healthcare and Patient SafetyOADove Medical Press · New Zealand | 1.10Q2 | 2.54 0.74 up from 2017 | 42 | 100% | $2,320 |
Subfields of Immunology and Microbiology, compared.
Journals
Citations made in 2018. Corpus-wide, 81.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
37 additional Immunology and Microbiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2015–2017, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2018. Publication window: 2015–2017. How these summaries are calculated
- Ranked journals
- 135
- Window papers (baseline)
- 122,958 +0.3% from indicator year 2015
- Median OJR
- 0.954 -9.4% from indicator year 2015
- Rising journals (2025)
- 12Comparison-group list (12)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2015–2017 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 84 | 87 | 84 | 88 | 92 | 96 | 96 | 99 | 100 | 109 | 113 | 118 | 117 | 124 | 126 | 135 | 135 | 131 | 134 | 128 | 131 | 132 | 133 | 130 | |
| Window papers (baseline) | 57,420 | 61,729 | 64,988 | 68,564 | 70,081 | 74,504 | 79,076 | 85,172 | 89,884 | 96,132 | 103,748 | 109,236 | 113,003 | 114,572 | 119,036 | 122,584 | 124,030 | 123,505 | 122,958 | 123,895 | 126,939 | 132,755 | 139,280 | 143,532 | 145,253 | 146,708 | |
| Median OJR | 0.70 | 0.78 | 0.80 | 0.76 | 0.79 | 0.837 | 0.88 | 0.945 | 0.98 | 1.15 | 1.11 | 1.089 | 1.07 | 1.04 | 1.052 | 1.053 | 1.092 | 0.99 | 0.954 | 0.948 | 0.89 | 0.847 | 0.841 | 0.854 | 0.87 | 0.853 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 116 journals |
| Retracted papers per 1,000 | Pooled rate: 1.118 per 1,000 | 102 journals |
| Output growth | Median: -14.5% | 121 journals |
| Open access share | Median: 82.5% | 130 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,340 | 99 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 25.3% | 128 journals |
| Review share | Median: 1.1% | 130 journals |
| Articles-only OJR | Median: 0.85 | 125 journals |
| Uncited share | Median: 25.6% | 130 journals |
| Citation concentration | Median: 42.4% | 130 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.